CDC Offers Guidance on Sexually Transmitted Ringworm (TMVII)

The infection, caused by Trichophyton mentagrophytes type VII (TMVII), presents as ring-shaped rashes on the genitals, groin, buttocks, and other areas, and is primarily associated with men who have sex with men, according to the CDC.

CDC Issues New Guidelines for Fungal Infection Linked to Sexual Activity

While ringworm is typically not classified as a sexually transmitted infection (STI), the CDC emphasized that TMVII’s unique transmission pattern necessitates targeted clinical awareness. The agency noted a significant cluster of cases in Minnesota, where public health officials credited early detection by clinicians for limiting further spread.

Minnesota Outbreak Demonstrates Critical Role of Early Detection

Clinicians are advised to consider TMVII when patients present with lesions in specific anatomical regions, including the genitals, perineum, or areas with hair such as the beard. The CDC’s guidance includes protocols for diagnostic testing, treatment, and reporting. Providers are urged to initiate oral antifungal therapy immediately if TMVII is strongly suspected, as treatment may take 6 to 12 weeks to fully resolve symptoms.

Clinicians Advised to Prioritize Specific Diagnostic Protocols

The agency also outlined steps for clinicians to report suspected cases to local health departments and seek assistance from the CDC via email for testing and management.

Prevention Strategies Focus on Hygiene and Behavioral Precautions

Prevention efforts focus on reducing transmission through hygiene practices and behavioral precautions. The CDC recommends that individuals with rashes avoid skin-to-skin contact, including sexual activity, until lesions have healed. Shared personal items such as towels, clothing, and sex toys should also be avoided to minimize spread.

Experts Warn of Misdiagnosis Risks and Need for Education

Public health experts caution that TMVII may be misdiagnosed as other STIs or skin conditions like eczema, highlighting the need for improved clinical education.

Rising STI Rates Underline Public Health Challenges

While TMVII is not life-threatening, its emergence underscores the evolving nature of infectious diseases and the importance of adaptive public health strategies. The CDC continues to monitor trends and provide resources to healthcare providers, emphasizing collaboration between clinicians, patients, and public health agencies to control the spread of the infection.

The agency’s recommendations come as part of ongoing efforts to combat sexually transmitted infections, including initiatives to expand access to pre-exposure prophylaxis (PrEP) and improve cervical cancer screening. Health officials stress that timely diagnosis and treatment remain the most effective tools for managing TMVII and other emerging health threats.